Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Wednesday, April 24, 2024

T.A.C jubilance gets reverberated with Debutant of the year from India...

New Delhi, June 13, 2022: India's fastest-growing D2C brand in the natural healthcare industry, The Ayurveda Company aka T.A.C has clinched another glory by...

Views from Mr. Ajoy Khandheria, Founder, Gramin Healthcare on One year...

New Delhi, September 25, 2019:  "Ayushman Bharat- National Health Protection Mission (AB-NHPM) is a revolutionary Scheme by Narendra Modi government. In just a year's...

Biotechnology

Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore

NEW DELHI,September  01 , 2023: Teestar® botanical chewables by Avesthagen Limited, a product designed for sugar and weight management, specifically targeting pre-diabetic and diabetic...

Intuitive and Max Healthcare to launch Southeast Asia’s first Total Program Observation Centre for...

Mumbai, August 24 , 2023: Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, and Max Healthcare, one...

IT & Software Support

Appointments

U Tropicana Alibaug appoints new Spa Manager from Thailand – Ms. Thanipawan Thavornpattarapong

Mumbai, April 24, 2019: U Tropicana, Alibaug is delighted to announce the appointment of Ms. Thanipawan Thavornpattarapong from Thailand as the Spa Manager at U Sante...

Les Roches Appoints New Managing Director for Global Campuses

New Delhi, June 02, 2019 : The governing board of Les Roches Global Hospitality Education, a top-ranked hospitality management institution with campuses in Switzerland,...

Awards

Financial Results

Hester Biosciences Ltd reports Net Profit of Rs. 3.56 crore and Revenues from Operations of Rs. 50.7 crore in Q1FY23

Ahmedabad, August 11, 2022: One of India's leading poultry and animal vaccine manufacturing company, Hester Biosciences Limited has...

Balaxi Pharmaceuticals reports continued solid growth in Q1 FY23

Revenue grows 42% in Q1FY23 Pharma Revenue in Latin America up 39%         ...

Morepen Labs’ Net Profit Rises by 153 Per cent Led by Strong API Business in Q1’FY 2020-21

New Delhi, August 31, 2020: Highlights: Q1’fy 2020-21 (Consolidated) Performance at a Glance (Rs. in Crores) Particulars Q1’FY 2020-21 Q1’FY...

Approvals

Sputnik V vaccine granted full permanent approval in Russia

Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world Sputnik V...

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Tribal eye Healthcare: Far from reality

Bengaluru, February 27, 2024: Despite commendable strides in healthcare, there remains a critical concern for the eye health of tribal communities in India. The unique...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Cyberabad Police Commissioner Sri V.C. Sajjanar has inaugurated Asian Institute of Nephrology and Urology...

Hyderabad, November 02, 2020: Asian Institute of Nephrology & Urology (AINU), a world-class, single-specialty, South India's largest centre for renal sciences hospital is expanding its...

Bio Innovations for Regenerative Agriculture

Hyderabad, November 02, 2021: Explaining the theme of the Bio-Agri 2021, India's biggest conference, "Bio Innovations for Regenerative Agriculture" Dr Venkatesh Devanur, Secretary of BIPA-Bio Agri...

Dental Care

Hospital Management

Common Symptoms of Gallbladder Cancer: Recognizing the Signs

By Dr Satya Srinivas A, Consultant - Medical Oncologist, HCG Cancer Centre, Vijaywada One of the most rare but serious forms of cancer is Gallbladder cancer...

Drug Discovery & Development

Suppliers

Technology

Revolutionizing technology that facilitates better outcomes for the patients in the...

~Kan Innovation - The powerful father-son duo's profound grasp of science~ New Delhi, November 10, 2022: With India's population plagued with problems like back pain,...

Companies

Ovarian Cancer Screening and Early Detection Strategies

Dr. Ranajit Kar, Sr. Consultant Radiation Oncology, HCG Panda Cancer Hospital, Cuttack   Ovarian cancer is known for its tendency to remain asymptomatic until it reaches...

Marketing

Our Partners

Machinery & Equipments